Nautilus Biotechnology, Inc. (NAUT) vs Palisade Bio, Inc. (PALI)
- Nautilus Biotechnology, Inc. NAUT 2.06 −4.63%
- Palisade Bio, Inc. PALI 1.41 −8.44%
Nautilus Biotechnology, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Palisade Bio, Inc. are of similar size ($274.9M and $268.4M). Nautilus Biotechnology, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −4,230.6%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 13 metrics below, Nautilus Biotechnology, Inc. leads on 7 and Palisade Bio, Inc. on 6.
Valuation
Profitability
| Metric | NAUT | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.63% | 65.16% |
| Operating margin | 0.00% | (4,681.99%) | 0.00% |
| Net margin | 0.00% | (4,230.60%) | 0.00% |
| Free cash flow margin | 0.00% | (2,409.27%) | 0.00% |
| Return on equity | (36.21%) | (51.37%) | (56.36%) |
| Return on assets | (30.00%) | (47.68%) | (48.04%) |
| Return on invested capital | (83.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack